Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
07:11:36 EDT Tue 21 Jul 2026
Enter Symbol
or Name
USA
CA



T:HBP - HELIX BIOPHARMA CORP. - https://www.helixbiopharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
HBP - T  0.50.95·1.440.71.43+0.032.1    5.40  0.95Jul 20Jun 3015 min RT 2¢
TSX - T0.50.95·1.440.71.43+0.032.1    5.40  0.95Jul 2015 min

Recent Trades - All 0 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2026-06-30 17:15C:HBP1.45News ReleaseHelix BioPharma Corp. Strengthens Executive Leadership to Support U.S. Listing Strategy and Next Phase of Clinical Development
2026-06-12 18:15C:HBP1.58News ReleaseHelix Biopharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Nine-Month Periods Ended April 30, 2026
2026-06-12 17:08C:HBP1.58SEDAR Interim MD & ASEDAR Interim MD & A
2026-06-12 17:05C:HBP1.58SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-06-03 17:15C:HBP1.58News ReleaseHelix BioPharma Corp. Announces Closing of Private Placement of Convertible Debentures
2026-05-22 17:32C:HBP1.63News ReleaseHelix BioPharma grants options to buy 1.29M shares
2026-05-13 16:15C:HBP1.60News ReleaseHelix Biopharma Corp. Announces Strategic Board and Governance Appointments to Support Financing and Nasdaq Uplisting Strategy
2026-03-16 17:42C:HBPSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-03-16 17:00C:HBP1.79News ReleaseHelix BioPharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Six-Month Periods Ended January 31, 2026
2026-03-16 16:23C:HBPSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-03-16 16:23C:HBPSEDAR Interim MD & ASEDAR Interim MD & A
2026-02-24 09:00C:HBP2.00News ReleaseHelix BioPharma Corp. Announces Presentation at 16th Annual World ADC London
2026-02-05 16:30C:HBP1.83News ReleaseHelix Biopharma Corp. Extends LEUMUNA Option with metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases
2026-01-30 18:03C:HBP2.03News ReleaseHelix BioPharma holders OK all business items at AGM
2025-12-15 17:30C:HBP2.05News ReleaseHelix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three-Month Period Ended October 31, 2025
2025-12-12 16:25C:HBP2.04SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-12-12 16:25C:HBP2.04SEDAR Interim MD & ASEDAR Interim MD & A
2025-10-29 17:59C:HBPSEDAR MD & ASEDAR MD & A
2025-10-29 13:52C:HBP2.09SEDAR Annual Information FormSEDAR Annual Information Form
2025-10-29 12:45C:HBP2.09News ReleaseHelix BioPharma Corp. Announces Fiscal 2025 Year-End Results